Elevated Plasma 4-pyridoxic Acid in Renal Insufficiency
Overview
Authors
Affiliations
Background: Renal insufficiency is associated with altered vitamin B-6 metabolism. We have observed high concentrations of 4-pyridoxic acid, the major catabolite of vitamin B-6 metabolism, in plasma during renal insufficiency.
Objective: The objective was to evaluate the renal handling of 4-pyridoxic acid and the effects of renal dysfunction on vitamin B-6 metabolism.
Design: We measured the renal clearance of 4-pyridoxic acid and creatinine in 17 nonpregnant, 17 pregnant, and 16 lactating women. We then examined the influence of vitamin B-6 or alkaline phosphatase activity on the ratio of 4-pyridoxic acid to pyridoxal (PA:PL) in plasma in 10 men receiving a low (0.4 mg pyridoxine.HCl/d) or high (200 mg pyridoxine.HCl/d) vitamin B-6 intake for 6 wk, in 10 healthy subjects during a 21-d fast, in 1235 plasma samples from 799 people screened for hypophosphatasia, and in 67 subjects with a range of serum creatinine concentrations.
Results: Renal clearance of 4-pyridoxic acid was 232 +/- 94 mL/min in nonpregnant women, 337 +/- 140 mL/min in pregnant women, and 215 +/- 103 mL/min in lactating healthy women. These values were approximately twice the creatinine clearance, indicating that 4-pyridoxic acid is at least partially eliminated by tubular secretion. Elevated plasma creatinine concentrations were associated with marked elevations in 4-pyridoxic acid and PA:PL. PA:PL was not affected by wide variations in vitamin B-6 intake or by the wide range of pyridoxal-P concentrations encountered while screening for hypophosphatasia.
Conclusions: Plasma 4-pyridoxic acid concentrations are markedly elevated in renal insufficiency. Plasma PA:PL can distinguish between increases in 4-pyridoxic acid concentrations due to increased dietary intake and those due to renal insufficiency.
Jing X, Ma Y, Li D, Zhang T, Xiang H, Xu F BMC Gastroenterol. 2024; 24(1):330.
PMID: 39350090 PMC: 11440720. DOI: 10.1186/s12876-024-03422-5.
Choi H, Madari S, Huang F Clin Pharmacokinet. 2024; 63(6):735-749.
PMID: 38867094 PMC: 11222257. DOI: 10.1007/s40262-024-01385-0.
Xiong L, Azad M, Liu Y, Zhang W, Zhu Q, Hu C Antioxidants (Basel). 2024; 13(3).
PMID: 38539817 PMC: 10967500. DOI: 10.3390/antiox13030283.
Thakur A, Mettu V, Singh D, Prasad B Biochem Pharmacol. 2023; 218:115867.
PMID: 37866801 PMC: 10900896. DOI: 10.1016/j.bcp.2023.115867.
Huh Y, Plotka A, Wei H, Kaplan J, Raha N, Towner J Pharm Res. 2023; 40(11):2639-2651.
PMID: 37561322 PMC: 10733197. DOI: 10.1007/s11095-023-03564-3.